PharmEvolution 2018IV International forum on pharmaceutical industry development in Russia
Today, pharmaceutics is one of the most successful sectors of the Russian economy. However, due to numerous recent changes in public administration, an important question arises: what will happen to the industry next? The state program «Pharma 2020» for industry development is finishing ahead of schedule. The results are good, but what future awaits the industry afterwards? How will regulators set the agenda in view of recent legislation? What will be the key events for the industry in 2018?
The IV Annual International Forum on Pharmaceutical Industry Development in Russia «PharmEvolution» is organized by the Vedomosti Business Daily in association with Kaluga Region Government, the Agency for Innovative Development – Center of Cluster Development of the Kaluga Region with the help of Kaluga Pharmaceutical Cluster. It will serve as a platform to bring together representatives and directors of federal government agencies and regional administrations, major pharmaceutical companies, business think tanks for scientific research and innovation, distributor companies and pharmacy chains, industry associations, unions, funds, management companies as well as lead analysts, investors, experts, and media.
- Strategic Development of Pharmaceutics through 2030. What's next?
- State price regulation for medicines and investment attractiveness of the pharmaceutics – how can we avoid negative consequences?
- Labeling of medicines – is the industry ready?
- How efficient is the program of the Ministry of Industry and Trade of the Russian Federation for localization of pharmaceutical production?
A business event that consists of a plenary session, two strategic sessions and a matchmaking for participants.
Kaluga, Innovative cultural center, 17 Oktyabrskaya Street.
Representatives of government departments of various levels, constituent entities of the Russian Federation, heads of industry enterprises and state corporations, senior and mid-level managers of international and Russian auto concerns and enterprises, automotive components manufacturers; Heads of procurement and development departments, technical and commercial directors, representatives of dealer centers, financial institutions, public organizations and professional associations, leading experts and market analysts, as well as representatives of business media.A special transfer from Moscow and back will be organized for participants from other regions.
If you have questions concerning the program, please contact project supervisor Evgenia Nikolaeva
+7 (495) 956-34-58, ext. 1285, or project coordinator Victoria Kim
+7 (495) 956-34-58, ext. 4224. If you have questions concerning advertising and sponsorship, please contact Ekaterina Osipenko
+7 (495) 956-34-58, ext. 190; for questions concerning information support and press accreditation, contact Anastasia Tiskova
+7 (495) 956-34-58, ext. 4147; for questions concerning participation, contact Yulia Lemasova
+7 (495) 956-34-58, ext. 1314.
10:00 a.m. – 11:00 a.m. Registration and welcome coffee.
11:00 a.m. – 1:30 p.m. Plenary session. Long-term Strategic Development of Pharmaceutics Industry through 2030. Trends and Prognoses.
, CEO, DSM GroupAnfisa Voronina
, Editor of Partnership projects, Vedomosti Business DailyKey Topics
- The main priorities of Pharma 2030
- Stimulating the «demand for innovation» in the health care system. What measures can «break through» existing barriers?
- State regulation of prices for VED — a step towards the introduction of a co-payment system
, Governor of Kaluga RegionIvan Glushkov
, Chairman of the Board, Kaluga Pharmaceutical ClusterVictor Dmitriev
, CEO, Association of the Russian Pharmaceutical Manufacturers (ARPM)Hans Duijf
, Vice-President and General Manager of Novo Nordisk Russia and BelarusNail Egofarov
, Public Affairs, Policy and Communication Director, Pfizer RussiaYury Krestinskiy
, Director, Research Centre for Economics and Management in Healthcare, Moscow School of Management SKOLKOVO Vadim Kukava
, Executive Director, Association InPharmaIrina Kurashkina
, Deputy Head of Division for Sectoral Planning and Strategic Development, Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of RussiaYulia Kurashvili
, Adviser to the General Director, Rusatom Healthcare Alexander Kuzin
, CEO, NovaMedicaSergey Lukiyan
, Head of the Kaluga branch, SberbankNikolay Lyskov
, a.i. Deputy Head of the Department of Chemistry, Biotechnology and Medicine, Federal Institute of Industrial PropertyAlexey Martynov
, Board Member, Expert, Agency for Strategic InitiativesMikhail Nekrasov
, CEO, Nanolek
1:30 p.m. – 2:30 p.m. Lunch.
2:30 p.m. – 4:30 p.m. Strategic Session 1. Labeling of Medicinal Products. Industry Data for the State and State Data for the Industry.
, Editor of Partnership projects, Vedomosti Business DailyIvan Glushkov
, Chairman of the Board, Kaluga Pharmaceutical Cluster Key Topics
- Labeling of other product groups: biologically active supplements, medical products, and pharmaceutical substances
- State financing program for purchasing equipment and software
- Equipment and software solutions for labeling — market overview
- Access to GIS «Labeling» data for market entitiеs
, Director, Exceed ConsultingDmitry Dunaevsky
, Commercial Director, OCS-TechnologyNelly Ignatieva
, Executive Director, Russian Association of Pharmacy ChainsVladlen Khvan
, Executive Director, VLADIFARMAndrey Kolesnikov
, Senior Director of Government Affairs and Market Access, Russia and Eurasia - Teva PharmaceuticalsGennady Pyatskiy
, General Manager, AstraZeneca IndustriesDmitry Scorchelletti
, Head of the Project Office, Centre for Development of Advanced TechnologiesArtem Selyanskiy
, FMD Project Manager at STADA RussiaAnna Simanovskaya
, Head of the Consulting Centre, Industrial Development FundLilia Titova
, Executive Director, Union of Professional Pharmaceutical Organizations
4:30 p.m. – 4:45 p.m. Coffee break.
4:45 p.m. – 5:45 p.m. Strategic session 2. Substance Production in Russia: To Be or Not to Be?
, Member of the Board of Directors, BIONKey Topics
- Localization of substance production — the real economy
- Measures of state support for the production of active substances
- Is it possible for Russian and foreign companies to cooperate in producing substances?
, Business Development Manager, Air LiquideDmitry Chagin
, Chairman of the Board, Association of Pharmaceutical Manufacturers of the Eurasian Economic UnionDmitry Skobelev
, Head, Bureau of Best Available Technologies*
* Сonfirmation was expected at the time of putting the booklet into print
5:45 p.m. – 7:00 p.m. MatchMaking.
5:45 p.m. – 7:00 p.m. Coffee break.